# Bristol-Myers Squibb Company (BMY) — Q1-2009 Earnings Results

**Report date:** 2009-04-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2009

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 4.3%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.48 | N/A | +1.69% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautious optimism regarding future growth. They emphasized the need to navigate current market conditions while focusing on innovation.

**Key quotes:**

> Management highlighted the importance of ongoing research and development.

> They expressed confidence in their pipeline but acknowledged market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a small beat on EPS, but the stock fell by 4.3% in reaction. Investors may be concerned about the lack of revenue details and forward guidance, which could indicate uncertainty about future performance. The cautious tone from management suggests they are aware of challenges ahead, which may have contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2009_